ZETA GLOBAL HOLDINGS CORP. (ZETA): what the price assumes
boothcheck covers ZETA GLOBAL HOLDINGS CORP. (ZETA) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed 2026-06-28.
Generated: 2026-09-19 · Source: https://boothcheck.com/report/ZETA
Headline
| Field | Value |
|---|---|
| Ticker | ZETA |
| Company | ZETA GLOBAL HOLDINGS CORP. |
| Current price | $30.16/sh |
| Composition | US 96% / International 4% |
What The Price Assumes (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Multiple paid | 292x operating income |
How unusual the bet is: n/a
Valuation X-Ray
The price is justified by relative-multiple and growth-DCF; asset-based/earnings-power land below the price.
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 8.31x | 2 | expensive |
| Earnings | 10.27x | 2 | expensive |
| Relative | 0.58x | 3 | justifies |
| Growth | 0.70x | 4 | justifies |
Families that justify the price: Relative, Growth Families that call it expensive: Asset, Earnings
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.0%); the inversion above states its own rate.
Per-Model Detail (n=11)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $42.00 | 0.72x | yes | FCF base $0.3B, growth 25% (input: historical growth), terminal g 4.0%, WACC 9.0%, 7yr projection |
| DCF Exit Multiple | Growth | $37.92 | 0.80x | yes | Exit EV/EBITDA: 63.9x / 66.9x / 69.9x (bear / base = today's held flat / bull), 7yr |
| Relative Valuation | Relative | $51.94 | 0.58x | yes | P/S fallback (negative EPS): Sector P/S 8.0x × TTM revenue — excluded from consensus |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $3.83 | 7.87x | yes | Book value floor: BV/sh $3.83, ROE negative |
| Two-Stage Excess Return | Asset | $3.45 | 8.74x | yes | Book value with convergence: BV/sh $3.83, ROE converges to ke |
| Discounted Future Market Cap | Growth | $43.76 | 0.69x | yes | Rev $1.6B, growth 30% (input: historical growth; tapered), Terminal P/S: 3.7x / 4.6x / 5.6x (bear / base = today's held flat / bull, cap 12x) |
| Peter Lynch Fair Value | Relative | $0.00 | — | no | Negative/zero EPS — earnings-based value floored at $0 |
| Margin Trajectory | Growth | $59.36 | 0.51x | yes | Margin ramp: -0% → 22% over 7yr, rev growth 30% (input: historical growth; tapered) |
| Earnings Power Value | Earnings | — | — | no | — |
| Residual Income | Asset | — | — | no | — |
| Graham Number | Asset | — | — | no | — |
| EV/EBITDA Relative | Relative | $11.51 | 2.62x | yes | EBITDA $0.11B × sector EV/EBITDA 25.0x |
| FCF Yield | Earnings | $10.40 | 2.90x | yes | FCF $224.4M / Kₑ 9.3% — zero-growth perpetuity |
| SBC-Adj FCF Yield | Earnings | $1.71 | 17.64x | yes | SBC-adj FCF $0.03B (FCF $0.22B − SBC $0.19B) capitalized at Kₑ |
| Ben Graham Formula | Earnings | — | — | no | — |
| ROIC-Justified P/B | Asset | $0.68 | 44.35x | yes | BV $3.83 × (ROIC 1.6% / WACC 9.0%) (excluded from median) |
| P/Sales Sector | Relative | $51.94 | 0.58x | yes | Revenue $1.57B × sector P/S 8.0x |
| PEG Fair Value | Relative | — | — | no | — |
| Earnings Yield | Earnings | — | — | no | — |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Economic-Unit Decomposition (Sum Of The Parts)
Only one reportable economic unit is present in the current topology source. Consolidated operating lenses remain available, but there is no multi-unit decomposition.
| Unit | Role | Valuation basis | Revenue | Reported profit | Value evidence | Status |
|---|---|---|---|---|---|---|
| Zeta Global (consolidated) | operating | enterprise | 1.3B reported-currency | — | withheld | unresolved no unit value |
No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.
Solvency
| Field | Value |
|---|---|
| Net cash | $112.5m |
| Net debt / NOPAT (after-tax) | -5.77x (net cash) |
| Net debt / operating income (pre-tax) | -4.56x (net cash) |
| Interest coverage | 16.1x |
| Share count CAGR (dilution) | 17.2% |
| Burning cash | no |
Bullet Takeaways
- Zeta Global runs an AI-driven marketing platform built on a large proprietary data set, and it monetizes by deepening its biggest accounts, with scaled-customer average revenue per user rising 13% to about $2.1 million in 2025.
- The defining risk is dilution: the company runs a real GAAP net loss, $31.5 million in 2025, that includes about $178 million of stock-based compensation, and the share count is growing at roughly 15% a year.
- What to watch is the growth mix: revenue rose 30% to $1.305 billion in 2025 and 2026 guidance implies 34% to 35% growth, but excluding political and the Marigold acquisition the organic rate is closer to 20% to 21%.
Bull Case
Marketing technology is a sector where the winner is whoever has the best data and can act on it fastest, and that is the lens through which Zeta's case is strongest. The platform combines a proprietary data set with AI to help brands target and message customers, and the company describes its edge as building "new products on a timely and cost-effective basis, meeting evolving customer needs, providing best-in-class data security, extending our core technology into new applications." In martech, scale begets scale: more customers and more data improve the models, which improves the targeting, which attracts more customers. Zeta is demonstrating that flywheel through its existing base rather than just new logos, with scaled-customer average revenue per user up 13% to about $2.1 million in 2025 and super-scaled accounts reaching about $6.16 million. Land-and-expand at that pace is the healthiest growth a software company can have, because it monetizes relationships it already paid to win.
The top-line momentum is genuinely strong. Full-year 2025 revenue grew 30% to $1.305 billion, the fourth quarter rose 25% to $395 million, and the company has now strung together eighteen consecutive beat-and-raise quarters. A consistent beat-and-raise record signals management is forecasting conservatively and executing ahead of its own guidance, which is the opposite of the over-promising that sinks many growth-software stories. The Marigold acquisition adds enterprise relationships and cross-sell, and 2026 guidance for 34% to 35% revenue growth reflects both the acquisition and continued organic strength in the low-twenties.
The inflection toward GAAP profitability is the part the market is starting to credit. Zeta posted positive GAAP net income of $6.5 million in the fourth quarter, a 1.7% margin, and guided to positive GAAP net income for full-year 2026. For a growth-software company, crossing into GAAP profitability while still growing north of 30% is the signal that the unit economics work and the model can self-fund. The valuation lenses reflect a name in transition: the relative-multiple and growth-DCF methods support the price, and analysts carry a strong-buy consensus with targets well above the current level.
Bear Case
The cleanest bear observation is that Zeta's reported profitability and its actual profitability are different numbers, and the gap is paid by shareholders. The company reported positive GAAP net income in the fourth quarter, but the full-year 2025 GAAP result was a net loss of $31.5 million, which included about $178 million of stock-based compensation. Stock-based compensation is a real cost, it is the equity handed to employees instead of cash, and at $178 million against a business this size it is the difference between the GAAP loss and the adjusted profit the company prefers to highlight. The consequence shows up directly in the share count, which is growing at roughly 15% a year. A company diluting holders at that pace has to grow per-share value much faster than total value just to stand still, and the buyer is funding the growth partly through their own dilution.
The growth itself deserves a second look. Headline 2026 guidance is for 34% to 35% revenue growth, but excluding political-candidate revenue and the Marigold acquisition, the underlying organic rate is 20% to 21%. Political revenue is episodic, tied to election cycles, and acquisition revenue is bought, not earned, so the durable organic engine is meaningfully slower than the headline suggests. For a stock whose price embeds years of high growth, the distinction between 35% reported and 20% organic is the whole valuation question, because the organic rate is what compounds after the election fades and the acquisition laps.
The structural risk is regulatory, and it sits at the heart of the business model. Zeta's value depends on collecting and acting on consumer data, and the 10-K is candid that regulation governs "the ways in which we may use or disclose data," that frameworks like "the GDPR permit data protection authorities to impose penalties for violations," and that the company expects "existing legal complexity and uncertainty regarding international data transfers to continue." Tightening privacy law, restrictions on data transfers, or the broader deprecation of tracking identifiers could erode the proprietary data advantage the entire thesis rests on. The valuation amplifies the stakes: at about 3.4 times revenue the price implies the business eventually earns a roughly 24% operating margin and grows at its self-funding ceiling for about six years, a path only about 28% of comparable fast-growers have sustained, and the asset and earnings-power lenses already call the price expensive. If the organic growth normalizes or a privacy shock hits, there is little static value beneath the price to catch it.
Valuation
Trailing operating profit sits below the steady-state level the price assumes, so the stock is best read against its sales rather than its earnings. At about 3.4 times revenue, the price implies the business eventually earns an operating margin near 24% and grows revenue at its self-funding ceiling for roughly six years. That is a demanding combination: the company must both scale its margin from today's near-breakeven GAAP level and sustain rapid growth, and only about 28% of comparable fast-growers have held this pace for six years. The read is labeled elevated, above what the fundamentals comfortably support.
The valuation families split as they do for a high-growth, not-yet-GAAP-profitable software name. The relative-multiple and growth-DCF lenses support the price, while the asset-based and earnings-power lenses call it expensive. The reconciliation is the margin-expansion story: the static methods value the thin current earnings, while the forward lenses credit the operating leverage the platform should produce as it scales. The price is paying for that leverage to materialize, which means the durability of the organic growth and the path to real GAAP margins, not just adjusted ones, are what the valuation rests on.
Solvency is adequate but not a fortress. The company holds modest net cash, about $91 million, against roughly $197 million of gross debt, and interest coverage is thin given the near-breakeven operating income. The more important balance-sheet fact is the equity dilution, not the debt: stock-based compensation around $178 million a year and a 15% annual increase in shares mean the per-share trajectory lags the total-business trajectory. The downside is not insolvency; it is a re-rating if organic growth slows toward the low twenties, if the margin expansion proves slower than the price assumes, or if data regulation pressures the model, against a price that only the growth-crediting lenses currently justify.
Catalysts
The fourth-quarter and full-year 2025 results, reported in early 2026, extended a long run of outperformance. Fourth-quarter revenue rose 25% to $395 million, full-year revenue grew 30% to $1.305 billion, and the company logged its eighteenth consecutive beat-and-raise quarter, while posting positive GAAP net income of $6.5 million in the quarter against a full-year GAAP net loss of $31.5 million driven by stock-based compensation. The scaled-customer monetization continued, with average revenue per user climbing on both scaled and super-scaled accounts.
The 2026 guidance and the Marigold acquisition are the forward catalysts. Management raised full-year 2026 revenue guidance to $1.749 to $1.762 billion, 34% to 35% growth, with organic growth excluding political and Marigold at 20% to 21%, and guided to adjusted EBITDA margins above 22% and positive full-year GAAP net income. The integration of Marigold and the cross-sell into its enterprise base is the lever to watch for whether the acquisition adds durable growth or just one-time scale.
Sentiment is strongly positive. Analysts carry a strong-buy consensus with an average price target around $28, and Bank of America raised its target to $28 with a buy rating. The events most likely to move the thesis from here are the organic-growth prints once political revenue fades, the pace of GAAP margin improvement against the heavy stock-based compensation, the integration of Marigold, and any change in the data-privacy regulatory landscape that bears on the platform's data advantage.
Peer Cohorts (Per Segment, With Filing Citations)
Zeta Global (consolidated) (reported)
- KVYO (Klaviyo, Inc.)
- FY2025 10-K: …among Klaviyo, Inc., Shopify Inc., Shopify International Limited, Shopify Commerce Singapore PTE. LTD., and Shopify Strategic Holdings 3 LLC, dated July 28, 2022. S-1 333-274211 10.12 August 25, 2023 10.12# Revenue Sharing Agreement by and between Klaviyo, Inc. and Shopify Inc., dated July 28, 2022. S-1 333-274211…
- FY2025 10-K: …together and uses it to create and deliver highly personalized consumer experiences across digital channels. 74 Table of Contents Results of Operations The following tables set forth our results of operations for the fiscal years presented and express the relationship of certain line items as a percentage of revenue…
- SEMR (Semrush Holdings, Inc.)
- FY2025 10-K: …the consolidated balance sheet as of December 31, 2025. The Company assigned a value of $ 1,062 to the acquired identifiable intangible assets consisting of content, customer relationships, and developed technology, which are amortized over the assets' useful lives using a straight-line amortization method. The…
- FY2025 10-K: …false 2025 FY 0001831840 P7Y 0.6667 iso4217:USD xbrli:shares iso4217:USD xbrli:shares semr:segment xbrli:pure semr:payment iso4217:PLN xbrli:shares semr:vote 0001831840 2025-01-01 2025-12-31 0001831840 2025-06-30 0001831840 us-gaap:CommonClassAMember 2026-02-24 0001831840 us-gaap:CommonClassBMember 2026-02-24…
- TTD (TRADE DESK, INC.)
- FY2025 10-K: …Accordingly, the Company operates in one operating segment on a consolidated basis: advertising technology platform. The Company's segment generates revenue from clients who enter into agreements with the Company to use its self-service, cloud-based ad buying platform. The accounting policies of the advertising…
- FY2025 10-K: …provides. As we expand relationships with our existing clients, we are investing in select regions in Europe and Asia. In particular, we believe that the United Kingdom ("U.K."), Germany, France, China, Japan, India and Australia may represent substantial growth opportunities, and we are investing in developing our…
- RAMP (LiveRamp Holdings, Inc.)
- FY2025 10-K: …goods, media, healthcare, travel and hospitality, entertainment and non-profit. Through our expansive partner ecosystem we serve thousands of additional companies, unlocking access to unique customer moments and creating powerful network effects. Basis of Presentation and Principles of Consolidation - The…
- FY2025 10-K: …three years ended March 31, 2025, March 31, 2024, and March 31, 2023, respectively. Other significant segment expenses within net earnings (loss) from continuing operations include other income (expense) (primarily interest income and expense), and income tax expense (benefit) that is presented in more detail in Note…
- DV (DoubleVerify Holdings, Inc.)
- FY2025 10-K: …22, 2025, the securities class action lawsuit previously disclosed on our Form 10-Q filed on November 7, 2025 was voluntarily dismissed by the lead plaintiffs without prejudice. 17. Segment Information The Company's CODM, the Chief Executive Officer, manages the Company's business activities as a single operating…
- FY2025 10-K: …goods, financial services, telecommunications, technology, automotive and healthcare. In 2025, we had 131 customers who each represented at least $1 million of annual revenue, up from 110 such customers in 2024 and 93 such customers in 2023, with no customer representing more than 10% of our revenue in 2025, 2024 or…
- TWLO (TWILIO INC.)
- FY2025 10-K: …2024, the related consolidated statements of operations, comprehensive income (loss), stockholders' equity, and cash flows for each of the years in the three-year period ended December 31, 2025, and the related notes (collectively, the consolidated financial statements). We also have audited the Company's internal…
- FY2025 10-K: …cost related to the 2016 ESPP was not significant. Stock-options and restricted stock units and awards activity under the Company's equity incentive plans is as follows: Stock Options Number of options outstanding Weighted- average exercise price (Per share) Weighted- average remaining contractual term (In years)…
- FRSH (Freshworks Inc.)
- FY2025 10-K: …a highly efficient inbound motion driven by PLG, as well as paid campaigns and search engine optimized (SEO) content marketing, affiliates and listings across peer review sites to drive organic traffic. Leads are ushered into a trial where they experience in-app triggers, lifecycle emails and functionality that…
- FY2025 10-K: …with U.S. generally accepted accounting principles (GAAP). The consolidated financial statements include the accounts of Freshworks and its wholly owned subsidiaries, and all intercompany balances and transactions have been eliminated in consolidation. Foreign Currency Remeasurement and Transactions The functional…
- PLTR (Palantir Technologies Inc.)
- FY2025 10-K: …market may limit our growth prospects and could adversely impact our business, results of operations, and financial condition, and we may not compete successfully against our current or potential competitors who choose to work in China. Joint ventures, channel sales relationships, platform partnerships, and strategic…
- FY2025 10-K: …based upon headcount at each operating segment during the period. We use it, in part, to evaluate the performance of, and allocate resources to, each of our operating segments, which excludes certain operating expenses that are not allocated to operating segments because they are separately managed at the…
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Economic-unit decomposition (SOTP): each disclosed business unit is assigned its native valuation basis before any multiple is applied. Operating units are valued on enterprise value; funded financial units are valued on their own common equity, because their borrowings fund earning assets rather than levering the parent. A company total is stated only once every material unit carries a supported value and the parent capital bridge reconciles.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.
Sources
Zeta Global Q4 2025 results and 2026 guidance · Zeta Global FY2025 10-K · Zeta Global Q4 2025 results, February 2026 · Zeta Global Q4 2025 results and guidance · analyst notes via stockanalysis.com and BofA, 2026 · Zeta Global Q4 2025 results · Zeta Global 2026 guidance